Nakajima, Shohei http://orcid.org/0000-0001-6820-4024
Sato, Iori
Soejima, Takafumi
Koh, Katsuyoshi
Kato, Motohiro
Okamoto, Yasuhiro
Imamura, Toshihiko
Maeda, Miho
Ishida, Yasushi
Manabe, Atsushi
Kamibeppu, Kiyoko
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP16ck0106071h0003, JP17ck0106334h0001)
Article History
Received: 26 February 2020
Accepted: 11 August 2020
First Online: 19 August 2020
Ethics approval and consent to participate
: Ethical Approval: All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The ALL-B12 was approved by the institutional review board of the Japanese Society of Pediatric Hematology/Oncology and the Graduate School of Medicine, University of Tokyo (No. 3871). It also received approval from each participating medical center and hospital. We obtained permission to use the anonymized data of participants from the JPLSG ALL committee.Informed Consent: We obtained written informed assent from all participants; especially under the age of 16, we obtained informed consent from all their guardians.
: Not applicable.
: The authors declare that they have no competing interests.